The new treatment of cervical cancer vaccine vector - tobacco
Georgetown University Medical Center and the North Carolina State University researchers using tobacco to produce antibodies for the human papilloma (HPV) virus gene fragments. This project has been $ 3 million of government funding. Georgetown University study for Dr. Kencomh Dretchen said, because HPV is the main risk factors of cervical cancer, the objective of this study is to be against the virus antibodies.
He said, "I do not know what reasons, in normal circumstances HPV difficult to growth and development." Therefore, we extracted from the HPV genetic material transplanted to the tobacco virus to amplified fragment.
Tags: age, anti, cancer, cause, clinical, eat, gene, growth, hpv, mass, risk, study, treatment